Letermovir and its role in the prevention of cytomegalovirus infection in seropositive patients receiving an allogeneic hematopoietic cell transplant

Cytomegalovirus (CMV) reactivation is one of the most common infections affecting allogeneic hematopoietic cell transplant recipients. Although available anti-CMV therapies have been evaluated for the prevention of CMV reactivation, their toxicity profile makes them unfavorable for use as primary pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Shigle, Terri Lynn, Handy, Victoria Wehr, Chemaly, Roy F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318821/
https://www.ncbi.nlm.nih.gov/pubmed/32637057
http://dx.doi.org/10.1177/2040620720937150

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318821/
https://www.ncbi.nlm.nih.gov/pubmed/32637057
http://dx.doi.org/10.1177/2040620720937150

Ejemplares similares